Martin Verhoef and William Rich | GenomeWeb

Martin Verhoef and William Rich


Martin Verhoef, senior vice president for sales, marketing, and operations, will become president of Ciphergen’s new Biosystems division, as well as executive vice president, and will report to William Rich, president and CEO, the company said last week. Verhoef, who has been with Ciphergen since April 2000, will lead the company’s research products group — which sells the company’s ProteinChip systems, arrays, and services — and the bioprocess products groups.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.